ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995